Welcome to our dedicated page for PERIMETER MED IMAGING AI news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on PERIMETER MED IMAGING AI stock.
Perimeter Medical Imaging AI, Inc. (PYNKF) is a commercial-stage medical technology company focused on transforming cancer surgery. Headquartered in Toronto, Canada, and Dallas, Texas, the company provides ultra-high-resolution, real-time, advanced imaging tools to address critical medical needs. With FDA-cleared Perimeter S-Series OCT system for cellular-level visualization and investigational Perimeter B-Series OCT with ImgAssist AI, Perimeter is at the forefront of utilizing artificial intelligence to enhance surgical outcomes and patient care.
Perimeter Medical Imaging AI announced its graduation from a Tier 2 Issuer to a Tier 1 Issuer on the TSX Venture Exchange, effective October 5, 2022. This upgrade reflects the Company’s significant financial resources and sustainable business model, with cash and cash equivalents totaling $44,966,273 as of June 30, 2022. The transition allows for the release of 5,080,959 shares from escrow, better positioning Perimeter for growth in the medical imaging sector.
Perimeter Medical Imaging AI, Inc. (OTC:PYNKF) has successfully placed its Perimeter S-Series OCT system in a major North Texas healthcare network hospital. This marks a significant step in validating their commercial model, highlighting their commitment to enhancing cancer surgery outcomes with advanced imaging technology. The Perimeter S-Series OCT offers real-time, high-resolution tissue visualization, aiming to reduce healthcare costs. CEO Jeremy Sobotta expressed enthusiasm about the system's potential impact on patient care and the interest from top surgeons.
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) reported its second quarter results on August 24, 2022. The company anticipates 10-20 commercial installations for its S-Series OCT device, reflecting increased market opportunities. Operating expenses amounted to $6.3 million, up from $3.1 million a year prior, while the net loss narrowed to $366,296 compared to $3.2 million in Q2 2021. Cash and cash equivalents stood at $44.97 million. The company is progressing in its pivotal clinical trial for the B-Series OCT system, with seven out of eight sites activated.
Perimeter Medical Imaging AI, Inc. (OTC:PYNKF) will announce its second quarter 2022 financial results after U.S. markets close on August 24, 2022. A conference call is scheduled for the same day at 5:00 PM ET, featuring key executives including CEO Jeremy Sobotta and CFO Chris Scott. Participants can join via dial-in or through a live webcast, with playback available for 14 days post-call. The company focuses on enhancing cancer surgery through innovative imaging solutions, including FDA-cleared systems for real-time visualization of excised tissues.
Perimeter Medical Imaging AI, Inc. (OTC:PYNKF) has announced the first commercial installation of its Perimeter S-Series OCT system at Pavilion Surgery Center in Orange, California. This advanced medical imaging technology enables real-time margin visualization during surgeries, enhancing breast cancer procedures. Cleared by the FDA in 2021, the system offers 10x higher resolution than standard imaging techniques, potentially improving patient outcomes and reducing healthcare costs. Leading surgeons are already utilizing the system to ensure clean margins during surgeries.
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) announces the appointment of Anantha Kancherla to its Board of Directors, effective immediately. Kancherla brings experience from leading tech firms like Microsoft and Facebook, which CEO Jeremy Sobotta believes will enhance their AI technology development. Perimeter's S-Series imaging technology is commercially available in the U.S., while the B-Series with AI is undergoing pivotal clinical trials. This leadership change comes at a crucial time for the company as it aims to innovate in cancer surgery imaging.
Perimeter Medical Imaging AI has appointed Chris Scott as the new Chief Financial Officer, effective immediately. Scott brings extensive experience in the medtech sector, having previously served as CFO at iRadimed Corporation (NASDAQ: IRMD) and successfully led them through an IPO, increasing their market cap from $10 million to $600 million. The company is well-positioned with a strong balance sheet and is focused on further developing its S-Series OCT and next-gen AI technology.
Perimeter Medical Imaging AI, Inc. (OTC:PYNKF) reported its Q1 2022 financials, highlighting a net loss of
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK, OTC:PYNKF) announced participation in the ROTH Canada Showcase Day on May 17, 2022, in New York, NY. The company aims to transform cancer surgery using advanced imaging tools. A presentation will be led by CEO Jeremy Sobotta at 12:00 p.m. ET. Investors can register for the webcast here.
Perimeter Medical Imaging AI (TSX-V:PINK)(OTC:PYNKF) announced a conference call to discuss its financial results for the year ending
FAQ
What is the current stock price of PERIMETER MED IMAGING AI (PYNKF)?
What is the market cap of PERIMETER MED IMAGING AI (PYNKF)?
What is Perimeter Medical Imaging AI, Inc. focused on?
Where is Perimeter Medical Imaging AI, Inc. headquartered?
What products does Perimeter Medical Imaging AI, Inc. offer?
What sets Perimeter Medical Imaging AI, Inc. apart in the medical technology industry?
How is Perimeter Medical Imaging AI, Inc. contributing to cancer surgery advancements?
What is the significance of Perimeter Medical Imaging AI, Inc.'s ticker symbol 'PINK'?
Where can I find more information about Perimeter Medical Imaging AI, Inc.'s disclosures and products?
What recent achievements has Perimeter Medical Imaging AI, Inc. showcased?
How can investors stay informed about Perimeter Medical Imaging AI, Inc.'s updates and performance?
What partnerships or collaborations has Perimeter Medical Imaging AI, Inc. established?
